Trial Number



Colorectal Cancer

Participant Age Range

18 years and older

Participant Gender

Female, Male

Enrolling Participants



Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Our goal is to provide Level 1 evidence that post-operative ctDNA status can be reliably used to determine intensity of adjuvant chemotherapy in patients with colon cancer. If this study is successful, the absence of ctDNA post-resection would subsequently guide medical oncologists to de-escalate the intensity of adjuvant therapy.


Related Clinical Trials

Click on the category you are interested in.

Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
Are you a current MemorialCare patient?
This registration is for:
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.